Scarica l'app Stockscreener
4.38
0.00%
0.00
Dopo l'orario di chiusura:
3.43
-0.95
-21.69%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Mimedx Group Inc Borsa (MDXG) Ultime notizie
Healing wounds with insights: How MiMedx powers innovation in healthcare with Strategy solutions - Strategy
ETF Watch: Whats the beta of MiMedx Group Inc stockQuarterly Profit Report & Fast Gaining Stock Reports - baoquankhu1.vn
MiMedx (MDXG) CCO receives shares from PSU vesting, with tax withholding - Stock Titan
MiMedx (NASDAQ: MDXG) GC gains PSU shares, withholds some for taxes - Stock Titan
Earnings Risk: Will MiMedx Group Inc announce a stock split2026 Highlights & Reliable Breakout Stock Forecasts - baoquankhu1.vn
How MiMedx Group Inc. stock performs in rising dollar environment2025 Growth vs Value & Accurate Intraday Trade Tips - Naître et grandir
Market Pulse: Can MiMedx Group Inc be recession proof2025 Momentum Check & Daily Volume Surge Signals - baoquankhu1.vn
MiMedx (MDXG) CEO Joseph Capper receives large stock and option awards - Stock Titan
MIMEDX (MDXG) CCO receives new stock option and restricted share grants - Stock Titan
This MiMedx Group analyst begins coverage on a bullish note; here are top 5 initiations for Monday - MSN
MiMedx Group, Inc. (MDXG) Partners with Vaporox for Advanced Wound Therapy - MSN
Trigran Investments Inc. Sells 689,430 Shares of MiMedx Group, Inc $MDXG - MarketBeat
MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields - Sahm
Aug Technicals: Is MiMedx Group Inc a speculative investmentJuly 2025 Trends & Low Drawdown Investment Ideas - baoquankhu1.vn
MiMedx (MDXG) Launches New AMNIOFIX Thyroid Shields - GuruFocus
MiMedx Group (NASDAQ:MDXG) Sets New 1-Year LowWhat's Next? - MarketBeat
The Rosen Law Firm Files Securities Fraud Class Action Against MiMedx Group, Inc.MDXG - AOL.com
MiMedx Group, Inc (MDXG) Stock Analysis: A Biotech Powerhouse with Nearly 100% Upside Potential - DirectorsTalk Interviews
InvestingPro Fair Value flagged MiMedx as overvalued before 47% drop By Investing.com - Investing.com Canada
Global Placenta Extract Market Size, Growth, Trends & Forecast to 2033 telaGen, BIOON, MiMedx Group - openPR.com
Analysts Issue Forecasts for MiMedx Group Q1 Earnings - MarketBeat
MiMedx Group (MDXG) Delivers Record Full Year Revenue - Finviz
MiMedx Group (NASDAQ:MDXG) Downgraded by Wall Street Zen to Buy - MarketBeat
Q2 EPS Estimates for MiMedx Group Lowered by Analyst - MarketBeat
MiMedx Group (NASDAQ:MDXG) Reaches New 1-Year LowWhat's Next? - MarketBeat
MiMedx Group (NASDAQ:MDXG) Stock Price Down 8.8%Here's What Happened - MarketBeat
MiMedx Group Q4 Earnings Call Highlights - Yahoo Finance
Transcript : MiMedx Group, Inc., Q4 2025 Earnings Call, Feb 25, 2026 - marketscreener.com
Earnings call transcript: MiMedx Q4 2025 sees robust growth, EPS beats forecast - Investing.com UK
MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results - The Globe and Mail
MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates - Nasdaq
MiMedx Group (NASDAQ:MDXG) Issues Quarterly Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
MIMEDX Group Inc (NASDAQ:MDXG) Stock Dips Despite Strong Earnings Beat - ChartMill
MiMedx (MDXG) Q4 2025 Earnings Call Transcript - AOL.com
MiMedx: Q4 Earnings Snapshot - marketscreener.com
Earnings Flash (MDXG) MiMedx Group, Inc. Posts Q4 Adjusted EPS $0.14 per Share, vs. FactSet Est of $0.09 - marketscreener.com
Earnings Flash (MDXG) MiMedx Group, Inc. Reports Q4 Revenue $118.1M, vs. FactSet Est of $106.8M - marketscreener.com
MiMedx (MDXG) details wound-care expansion, new products and Medicare shifts - Stock Titan
MiMedx Group, Inc. announces an Equity Buyback for $100 million worth of its shares. - marketscreener.com
What to Expect from MiMedx Group's Earnings - Benzinga
MiMedx Group Inc (MDXG) Q4 2025 Earnings Report Preview: What to Look For - GuruFocus
MiMedx Group, Inc (MDXG) Stock Analysis: Exploring an 81% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
MiMedx Group (MDXG): Citizens Initiates Coverage with Market Out - GuruFocus
MiMedx Group (NASDAQ:MDXG) Now Covered by Citizens Jmp - MarketBeat
MiMedx Group, Inc (NASDAQ:MDXG) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Beyond The Numbers: 4 Analysts Discuss MiMedx Group Stock - Benzinga
This MiMedx Group Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Citizens Initiates Coverage of MiMedx Group (MDXG) with Market Outperform Recommendation - Nasdaq
Citizens initiates MiMedx stock with outperform on reimbursement outlook By Investing.com - Investing.com Canada
Citizens initiates MiMedx stock with outperform on reimbursement outlook - Investing.com
How The MiMedx (MDXG) Investment Story Is Resetting Around CMS And Analyst Revisions - Yahoo Finance
What catalysts could drive MiMedx Group Inc. stock higherJuly 2025 Market Mood & Breakout Confirmation Trade Signals - mfd.ru
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):